AbbVie, Inc. (ABBV)

256.46 -3.75 (-1.44%) USD  |  NYSE  |  Sep 04, 16:00
256.40 -0.06 (-0.02%) Pre-Market: 20:00
More

AbbVie SG&A Expense (TTM) : 14.67B for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ABBV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 14.67B
March 31, 2026 14.30B
December 31, 2025 14.01B
September 30, 2025 13.97B
June 30, 2025 14.61B
March 31, 2025 14.73B
December 31, 2024 14.75B
September 30, 2024 14.09B
June 30, 2024 13.26B
March 31, 2024 13.15B
December 31, 2023 12.87B
September 30, 2023 13.10B
June 30, 2023 13.03B
March 31, 2023 15.17B
December 31, 2022 15.26B
September 30, 2022 15.10B
June 30, 2022 14.88B
March 31, 2022 12.63B
December 31, 2021 12.35B
September 30, 2021 12.32B
June 30, 2021 12.08B
March 31, 2021 12.45B
December 31, 2020 11.30B
September 30, 2020 10.02B
June 30, 2020 8.83B
Date Value
March 31, 2020 6.957B
December 31, 2019 6.942B
September 30, 2019 6.92B
June 30, 2019 7.182B
March 31, 2019 7.288B
December 31, 2018 7.399B
September 30, 2018 7.426B
June 30, 2018 6.964B
March 31, 2018 6.708B
December 31, 2017 6.285B
September 30, 2017 5.982B
June 30, 2017 5.906B
March 31, 2017 5.868B
December 31, 2016 5.855B
September 30, 2016 5.939B
June 30, 2016 6.032B
March 31, 2016 6.269B
December 31, 2015 6.387B
September 30, 2015 7.991B
June 30, 2015 8.112B
March 31, 2015 7.857B
December 31, 2014 7.724B
September 30, 2014 5.831B
June 30, 2014 5.497B
March 31, 2014 5.455B

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Biogen, Inc. 2.594B
Gilead Sciences, Inc. 9.147B
Regeneron Pharmaceuticals, Inc. 2.743B
Amgen, Inc. 7.019B
REGENXBIO, Inc. 85.56M